The puzzling in¯ammatory bowel disease: growing interest for mediators of in¯ammation
In this issue of Medi ators of In amm ation two review articles and one research paper describe the local in ammation in the colon and the role of cytokines, leukocyte migration and the effect of cell± cell interaction on cytokine synthesis. In the paper by Beck and Wallace an overview is given of so far known important pro-in ammatory cytokines (IL-1, IL-2, IL-5, IL-6, IL-8, TNFa and IFNc) and anti-in ammatory cytokines (IL-4, IL-10, IL-11, IL-13 and TGFb). 1 In addition the migration of leukocytes, mediated by adhesion molecules such as selectins, chemokines and integrins, is reviewed by van Rees et al. 2 During or after this migration lymphocytes could stimulate the synthesis of the pro-in ammatory cytokines IL-2 and IFNc, as described by Hoang et al. 3 Recently it has been described by Smith et al. that IL-1b stimulates the LPS-induced PGE 2 synthesis by the colonocyte cell line CACO-2, whereas LTB 4 was uneffected. 4 After simultaneous incubation with IL-1ra the elevated levels of PGE 2 were completely abolished, although a signi cant increase in LTB 4 was observed. This could be due to the lack of feedback inhibition by substantial amounts of PGE 2 .
In the December 1995 issue of Medi ators of In amm ation two debate articles on the involvement of nitric oxide as pro-or anti-in ammatory mediator were published, 5, 6 again re ecting Janus, the symbol for mediators of in ammation, which exert both harmful and bene cial functions.
In summary, from the above-mentioned ndings it could be concluded that in in ammatory bowel disease (IBD) mediators of in ammation are involved which could be considered as (a) pro-or anti-in ammatory mediators, (b) primary or secondary mediators, (c) proteins, lipid mediators or otherwise, (d) T H 1-or T H 2-cell derived substances. Furthermore migrated cells could amplify synthesis of mediators by cells localized in the lamina propia. Moreover one should consider that IBD include two different diseases (Crohn's disease and ulcerative colitis) which, though displaying similar aspects of in ammatory features in the colon, nevertheless require distinct medical treatment.
The adequate therapy of patients not responding to classical treatment with corticosteroids nowadays includes the experimental use of antiTNFa and IL-10 in Crohn's disease, 7, 8 whereas nicotine also has proven to be bene cial in ulcerative colitis. 9 Such treatment regimens imply knowledge about mechanisms of action underlying biochemical aspects of acute, subacute and chronic phenomena of colonic inammation. So far we may conclude that corticosteroids will suppress all mediators, whereas 5-aminosalicylic acid (5-ASA) partly attenuates cytokine synthesis. Although nicotine probably acts through inhibition of eicosanoids and pro-inammatory cytokines, 10, 11 it is not yet clear why nicotine (including the otherwise harmful habit of smoking) is good for ulcerative colitis and bad for Crohn's disease. 12 This could be related to the T H 1-and T H 2-cell speci c aspects seen in IBD. 13 On the other hand con icting results were obtained from investigations in Crohn's disease and ulcerative colitis in which IFNc, IL-2 and IL-10 were all increased. 14, 15 Up to now it is not quite clear whether nicotine selectively inhibits pro-in ammatory cytokines derived from T H 1-cells or not, since we observed that IL-10 was decreased after nicotine in vivo. 13 Finally cyclosporin has been reported to be effective in IBD. Both T cell proliferation and the production of T cell-derived cytokines is inhibited. 16 The reduction of T cell migration might be another fruitful area for future studies. 2, 17 Knowledge of the potential T-cell subsets to
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generate pro-and anti-in ammatory cytokines in IBD, which in turn affect secondary mediators such as eicosanoids, could contribute to the understanding of these puzzling diseases and subsequently lead to the development of more adequate medicines to prevent severe exacerbations during the chronic phase of the disease.
Submission of research papers on this subject would be welcomed for forthcoming issues of 
